Further structure-activity relationships study of substituted dithiolethiones as glutathione-inducing neuroprotective agents.

Background: Parkinson's disease is a neurodegenerative disorder associated with oxidative stress and glutathione depletion. The induction of cellular glutathione levels by exogenous molecules is a promising neuroprotective approach to limit the oxidative damage that characterizes Parkinson's disease pathophysiology. Dithiolethiones, a class of sulfur-containing heterocyclic molecules, are known to increase cellular levels of glutathione; however, limited information is available regarding the influence of dithiolethione structure on activity. Herein, we report the design, synthesis, and pharmacological evaluation of a further series of dithiolethiones in the SH-SY5Y neuroblastoma cell line.

Results: Our structure-activity relationships data show that dithiolethione electronic properties, given as Hammett σ constants, influence glutathione induction activity and compound toxicity. The most active glutathione inducer identified, , dose-dependently protected cells from 6-hydroxydopamine toxicity. Furthermore, the protective effects of were abrogated by the inhibitor of glutathione synthesis, buthionine sulfoximine, confirming the importance of glutathione in the protective activities of .

Conclusions: The results of this study further delineate the relationship between dithiolethione chemical structure and glutathione induction. The neuroprotective properties of analog suggest a role for dithiolethiones as potential antiparkinsonian agents.